- Home
- ORIC vs MAX Comparison
ORIC vs MAX Comparison
Compare ORIC & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | MAX |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 732.5M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ORIC | MAX |
|---|---|---|
| Price | $12.79 | $12.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $19.73 | $12.70 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.67 | ★ 25.81 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $1,113,600,000.00 |
| Revenue This Year | N/A | $13.42 |
| Revenue Next Year | N/A | $8.16 |
| P/E Ratio | ★ N/A | $14.40 |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $7.23 | $7.09 |
| 52 Week High | $14.93 | $14.70 |
Technical Indicators
Market Signals| Indicator | ORIC | MAX |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 43.71 |
| Support Level | $10.45 | $11.09 |
| Resistance Level | $13.89 | $14.21 |
| Average True Range (ATR) | 1.02 | 0.72 |
| MACD | 0.06 | -0.31 |
| Stochastic Oscillator | 67.09 | 7.09 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.